Next Article in Journal
Divergent Dynamics and Functions of ERK MAP Kinase Signaling in Development, Homeostasis and Cancer: Lessons from Fluorescent Bioimaging
Next Article in Special Issue
The Role of HOX Transcription Factors in Cancer Predisposition and Progression
Previous Article in Journal
LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics
Previous Article in Special Issue
Kinase Regulation of HOX Transcription Factors
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessReview
Cancers 2019, 11(4), 512; https://doi.org/10.3390/cancers11040512

A Case of Identity: HOX Genes in Normal and Cancer Stem Cells

1,2,†, 1,2,† and 1,2,*
1
SVMS, Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK
2
Nottingham Breast Cancer Research Centre and Centre for Cancer Sciences, University of Nottingham, Centre for Biomolecular Sciences, Nottingham NG7 2RD, UK
*
Author to whom correspondence should be addressed.
These authors contributed equally to the paper.
Received: 21 March 2019 / Revised: 8 April 2019 / Accepted: 9 April 2019 / Published: 10 April 2019
(This article belongs to the Special Issue HOX Genes in Cancer)
  |  
PDF [682 KB, uploaded 23 April 2019]
  |  

Abstract

Stem cells are undifferentiated cells that have the unique ability to self-renew and differentiate into many different cell types. Their function is controlled by core gene networks whose misregulation can result in aberrant stem cell function and defects of regeneration or neoplasia. HOX genes are master regulators of cell identity and cell fate during embryonic development. They play a crucial role in embryonic stem cell differentiation into specific lineages and their expression is maintained in adult stem cells along differentiation hierarchies. Aberrant HOX gene expression is found in several cancers where they can function as either oncogenes by sustaining cell proliferation or tumor-suppressor genes by controlling cell differentiation. Emerging evidence shows that abnormal expression of HOX genes is involved in the transformation of adult stem cells into cancer stem cells. Cancer stem cells have been identified in most malignancies and proved to be responsible for cancer initiation, recurrence, and metastasis. In this review, we consider the role of HOX genes in normal and cancer stem cells and discuss how the modulation of HOX gene function could lead to the development of novel therapeutic strategies that target cancer stem cells to halt tumor initiation, progression, and resistance to treatment. View Full-Text
Keywords: HOX genes; stem cells; cancer stem cells; self-renewal; differentiation; targeted therapy HOX genes; stem cells; cancer stem cells; self-renewal; differentiation; targeted therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Smith, J.; Zyoud, A.; Allegrucci, C. A Case of Identity: HOX Genes in Normal and Cancer Stem Cells. Cancers 2019, 11, 512.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top